Thomas Ruzicka

39.2k total citations · 5 hit papers
672 papers, 26.2k citations indexed

About

Thomas Ruzicka is a scholar working on Dermatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Thomas Ruzicka has authored 672 papers receiving a total of 26.2k indexed citations (citations by other indexed papers that have themselves been cited), including 294 papers in Dermatology, 131 papers in Epidemiology and 129 papers in Molecular Biology. Recurrent topics in Thomas Ruzicka's work include Dermatology and Skin Diseases (117 papers), Autoimmune Bullous Skin Diseases (53 papers) and Nonmelanoma Skin Cancer Studies (48 papers). Thomas Ruzicka is often cited by papers focused on Dermatology and Skin Diseases (117 papers), Autoimmune Bullous Skin Diseases (53 papers) and Nonmelanoma Skin Cancer Studies (48 papers). Thomas Ruzicka collaborates with scholars based in Germany, United States and Hungary. Thomas Ruzicka's co-authors include Ulrich R. Hengge, Gerd G. Gauglitz, Jürgen Schauber, Percy Lehmann, Hans Christian Körting, Robert A. Schwartz, Carola Berking, Bernhard Homey, Marc G. Jeschke and Michael J. Cork and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Thomas Ruzicka

649 papers receiving 25.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies

2010 1.0k citations Gerd G. Gauglitz, Thomas Ruzicka et al. profile →
Adverse effects of topical glucocorticosteroids

2005 761 citations Thomas Ruzicka et al. profile →
IL-31: A new link between T cells and pruritus in atopic skin inflammation

2006 709 citations Enikö Sonkoly, Anja Müller et al. profile →
CCL27–CCR10 interactions regulate T cell–mediated skin inflammation

2002 592 citations Bernhard Homey, Harri Alenius et al. profile →
Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis

2017 414 citations Thomas Ruzicka, Andreas Wollenberg et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Ruzicka Germany	81	11.9k	6.2k	5.7k	3.8k	3.7k	672	26.2k
Giampiero Girolomoni Italy	81	9.9k 0.8×	12.5k 2.0×	3.1k 0.6×	2.4k 0.6×	3.8k 1.0×	558	23.7k
Juliet N. Barker United States	85	9.0k 0.8×	17.3k 2.8×	4.4k 0.8×	2.9k 0.8×	2.1k 0.6×	559	31.3k
Wolfram Sterry Germany	81	13.4k 1.1×	8.5k 1.4×	3.6k 0.6×	5.2k 1.3×	1.2k 0.3×	671	27.1k
Bernhard Homey Germany	61	6.7k 0.6×	11.4k 1.8×	4.4k 0.8×	1.5k 0.4×	3.9k 1.1×	263	23.1k
Kenji Kabashima Japan	77	10.9k 0.9×	7.6k 1.2×	3.1k 0.6×	1.1k 0.3×	6.8k 1.8×	483	22.4k
Enno Christophers Germany	66	6.0k 0.5×	10.1k 1.6×	3.7k 0.6×	1.9k 0.5×	2.0k 0.5×	362	18.9k
Brian J. Nickoloff United States	76	5.6k 0.5×	9.1k 1.5×	5.3k 0.9×	1.7k 0.5×	1.3k 0.3×	239	19.0k
Mark R. Pittelkow United States	77	6.0k 0.5×	3.5k 0.6×	5.3k 0.9×	3.0k 0.8×	862 0.2×	366	19.2k
Lars E. French Switzerland	70	5.2k 0.4×	7.3k 1.2×	6.7k 1.2×	3.8k 1.0×	701 0.2×	482	21.2k
Raif S. Geha United States	99	4.3k 0.4×	19.4k 3.1×	5.3k 0.9×	2.4k 0.6×	6.5k 1.7×	501	31.8k

Countries citing papers authored by Thomas Ruzicka

Since Specialization

Citations

This map shows the geographic impact of Thomas Ruzicka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ruzicka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ruzicka more than expected).

Fields of papers citing papers by Thomas Ruzicka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Ruzicka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ruzicka. The network helps show where Thomas Ruzicka may publish in the future.

Co-authorship network of co-authors of Thomas Ruzicka

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Ruzicka. A scholar is included among the top collaborators of Thomas Ruzicka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Ruzicka. Thomas Ruzicka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Plewig, Gerd, Lars E. French, Thomas Ruzicka, Roland Kaufmann, & Michael Hertl. (2022). Braun-Falco´s Dermatology. 8 indexed citations

Vural, Seçil, Martina Baumgartner, Peter Lichtner, et al.. (2021). Investigation of gamma secretase gene complex mutations in German population with Hidradenitis suppurativa designate a complex polygenic heritage. Journal of the European Academy of Dermatology and Venereology. 35(6). 1386–1392. 12 indexed citations

Niculescu, Liviu, Cristel Ruini, Jerome Srour, et al.. (2018). Tazarotene 0.015% Cream as a Potential Topical Agent for Management of Ichthyosis in Dorfman-Chanarin Syndrome. Acta Dermato Venereologica. 99(3). 345–346. 4 indexed citations

Vural, Seçil, Atay Vural, Fulya Akçimen, et al.. (2018). Clinical and molecular characterization and response to acitretin in three families with Sjögren‐Larsson syndrome. International Journal of Dermatology. 57(7). 843–848. 6 indexed citations

Vural, Seçil, Atay Vural, Lars Steinmüller‐Magin, et al.. (2018). Association of pyrin mutations and autoinflammation with complex phenotype hidradenitis suppurativa: a case–control study. British Journal of Dermatology. 180(6). 1459–1467. 34 indexed citations

Horváth, Orsolya N., et al.. (2016). Periocular discoloration after using a prostaglandin analog for eyelash enhancement: evaluation with reflectance confocal microscopy. Journal of Cosmetic Dermatology. 16(1). 18–20. 7 indexed citations

Molin, Sonja, Juliane Merl, M. Regauer, et al.. (2014). The hand eczema proteome: imbalance of epidermal barrier proteins. British Journal of Dermatology. 172(4). 994–1001. 42 indexed citations

Dáňová, Jana, et al.. (2014). Risk factors for malignant melanoma and preventive methods.. PubMed. 94(5). 241–8. 15 indexed citations

Ruzicka, Thomas, et al.. (2014). Understanding the safety and tolerability of facial filling therapeutics. Expert Opinion on Drug Safety. 13(9). 1215–1226. 18 indexed citations

10.

Gáspár, Krisztián, Gabriela Kukova, Erich Bünemann, et al.. (2013). The chemokine receptor CCR3 participates in tissue remodeling during atopic skin inflammation. Journal of Dermatological Science. 71(1). 12–21. 39 indexed citations

11.

Bakos, Renato Marchiori, et al.. (2011). Risk factors for early-onset basal cell carcinoma in a German institution. European Journal of Dermatology. 21(5). 705–709. 24 indexed citations

12.

Hegyi, Juraj, et al.. (2011). New developments in fluorescence diagnostics: Developments in fluorescence diagnostics. 9(5). 368–372. 2 indexed citations

13.

Besch, Robert, Hendrik Poeck, Tobias Hohenauer, et al.. (2009). Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon–independent apoptosis in human melanoma cells. Journal of Clinical Investigation. 119(8). 2399–411. 350 indexed citations

14.

Eigelshoven, Sibylle, et al.. (2009). Cytokeratin 18 expression in immature Sertoli cells: co-localization with interstitial lymphocytic infiltrates.. SHILAP Revista de lepidopterología.

15.

Wolf, Ronald, et al.. (2007). Human S100A15 splice variants are differentially expressed in inflammatory skin diseases and regulated through Th1 cytokines and calcium. Experimental Dermatology. 16(8). 685–691. 32 indexed citations

16.

Gollnick, Harald, Carlos Guillén Barona, Thomas Ruzicka, et al.. (2006). Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe.. PubMed. 15(5). 374–81. 55 indexed citations

17.

Ruzicka, Thomas & Sakari Reitamo. (2004). Tacrolimus ointment : a topical immunomodulator for atopic dermatitis. Springer eBooks. 2 indexed citations

18.

Fritsch, Clemens, P. Becker‐Wegerich, K.W. Schulte, et al.. (1996). Photodynamische Therapie und Mamillenplastik eines großflächigen Rumpfhautbasalioms der Mamma Effektive Kombinationstherapie unter photodynamischer Diagnostik. Der Hautarzt. 47(6). 438–442. 1 indexed citations

19.

Michel, Günter, et al.. (1994). IL-6 is a potent inducer of IL-13 mRNA in normal human keratinocytes. Journal of Investigative Dermatology. 103(3). 433. 4 indexed citations

20.

Ruzicka, Thomas. (1985). [Leukotrienes and monohydroxy fatty acids: controversial role in the pathogenesis of psoriasis].. PubMed. 36(5). 255–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact